237 related articles for article (PubMed ID: 28859932)
21. [Helical tomotherapy in the treatment of malignant pleural mesothelioma: The impact of low doses on pulmonary and oesophageal toxicity].
Helou J; Clément-Colmou K; Sylvestre A; Campion L; Amessis M; Zefkili S; Raphael J; Bonnette P; Le Pimpec Barthes F; Périgaud C; Mahé MA; Giraud P
Cancer Radiother; 2013 Dec; 17(8):755-62. PubMed ID: 24269017
[TBL] [Abstract][Full Text] [Related]
22. Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study.
Botticella A; Defraene G; Nackaerts K; Deroose CM; Coolen J; Nafteux P; Peeters S; Ricardi U; De Ruysscher D
Acta Oncol; 2016 Dec; 55(12):1450-1455. PubMed ID: 27732127
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma.
Matsuo Y; Shibuya K; Okubo K; Ueki N; Aoyama A; Sonobe M; Nakamura M; Mizowaki T; Date H; Hiraoka M
Acta Oncol; 2017 Jul; 56(7):957-962. PubMed ID: 28117611
[TBL] [Abstract][Full Text] [Related]
24. Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States.
Shaaban SG; Verma V; Choi JI; Shabason J; Sharma S; Glass E; Grover S; Badiyan SN; Simone CB
Clin Lung Cancer; 2018 Sep; 19(5):e685-e692. PubMed ID: 29803576
[TBL] [Abstract][Full Text] [Related]
25. Radiation therapy for malignant pleural mesothelioma.
Rosenzweig KE; Giraud P
Cancer Radiother; 2017 Feb; 21(1):73-76. PubMed ID: 28237609
[TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated radiotherapy is a safe and effective treatment for localized malignant pleural mesothelioma.
Simon M; Shochat T; Peled N; Zer A; Kramer MR; Eldan O; Saute M; Dudnik ER; Allen AM
Thorac Cancer; 2018 Nov; 9(11):1470-1475. PubMed ID: 30240138
[TBL] [Abstract][Full Text] [Related]
27. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
[TBL] [Abstract][Full Text] [Related]
28. A novel radiation therapy technique for malignant pleural mesothelioma combining electrons with intensity-modulated photons.
Chan MF; Chui CS; Song Y; Burman C; Yorke E; Della-Biancia C; Rosenzweig KE; Schupak K
Radiother Oncol; 2006 May; 79(2):218-23. PubMed ID: 16698098
[TBL] [Abstract][Full Text] [Related]
29. High-dose palliative radiotherapy for malignant pleural mesothelioma.
Foroudi F; Smith JG; Putt F; Wada M
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):797-803. PubMed ID: 28727277
[TBL] [Abstract][Full Text] [Related]
30. Disease-Related Outcomes and Toxicities of Intensity Modulated Radiation Therapy After Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic Review.
Patel R; Ludmir EB; Miccio JA; Menon H; Barsky AR; Mesko SM; Kodali M; Lautenschlaeger T; Adeberg S; Simone CB; Verma V
Pract Radiat Oncol; 2020; 10(6):423-433. PubMed ID: 32088429
[TBL] [Abstract][Full Text] [Related]
31. Tomotherapy PET-guided dose escalation: A dosimetric feasibility study for patients with malignant pleural mesothelioma.
Maggio A; Cutaia C; Di Dia A; Bresciani S; Miranti A; Poli M; Del Mastro E; Garibaldi E; Gabriele P; Stasi M
Strahlenther Onkol; 2016 Feb; 192(2):102-8. PubMed ID: 26453534
[TBL] [Abstract][Full Text] [Related]
32. Intensity-modulated photon arc therapy for treatment of pleural mesothelioma.
Tobler M; Watson G; Leavitt DD
Med Dosim; 2002; 27(4):255-9. PubMed ID: 12521069
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy for the treatment of malignant pleural mesothelioma.
de Perrot M; Wu L; Wu M; Cho BCJ
Lancet Oncol; 2017 Sep; 18(9):e532-e542. PubMed ID: 28884702
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial.
Bayman N; Appel W; Ashcroft L; Baldwin DR; Bates A; Darlison L; Edwards JG; Ezhil V; Gilligan D; Hatton M; Jegannathen A; Mansy T; Peake MD; Pemberton L; Rintoul RC; Snee M; Ryder WD; Taylor P; Faivre-Finn C
J Clin Oncol; 2019 May; 37(14):1200-1208. PubMed ID: 30920878
[TBL] [Abstract][Full Text] [Related]
35. Extra-pleural pneumonectomy in the era of image-guided intensity-modulated radiotherapy.
Trovo M; Franceschini D; Furlan C; Pietrobon F; Vagge S; Farina E; Revelant A; Visani L; Maragna V; Parisi G; Scotti V
Radiol Med; 2019 Sep; 124(9):854-859. PubMed ID: 30963379
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs.
Thompson MR; Dumane VA; Lazarev SA; Zia Y; Rosenzweig KE
Pract Radiat Oncol; 2019 May; 9(3):e331-e337. PubMed ID: 30654090
[TBL] [Abstract][Full Text] [Related]
37. Geometric dose prediction model for hemithoracic intensity-modulated radiation therapy in mesothelioma patients with two intact lungs.
Kuo L; Yorke ED; Dumane VA; Foster A; Zhang Z; Mechalakos JG; Wu AJ; Rosenzweig KE; Rimner A
J Appl Clin Med Phys; 2016 May; 17(3):371-379. PubMed ID: 27167294
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic intensity-modulated radiation therapy (IMRT) and inverse treatment planning for advanced pleural mesothelioma. Feasibility and initial results.
Münter MW; Nill S; Thilmann C; Hof H; Höss A; Häring P; Partridge M; Manegold C; Wannenmacher M; Debus J
Strahlenther Onkol; 2003 Aug; 179(8):535-41. PubMed ID: 14509952
[TBL] [Abstract][Full Text] [Related]
39. Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival.
Jhavar S; Pruszynski J; Gowan A; Boyle T; Deb N; Patel M
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e88-e94. PubMed ID: 28371288
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic Radiotherapy to Intervention Sites in Malignant Pleural Mesothelioma--Single-institution Experience and Literature Review.
Janssen S; Schönhofer B; Rades D
Anticancer Res; 2015 Jul; 35(7):4151-4. PubMed ID: 26124370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
